XNK Therapeutics

Huddinge, Sweden

XNK Therapeutics is a clinical stage, immunotherapy company.

$156K raised

Oct 2023

Grant

Pharmaceutical Therapeutics

Top Investors

Vinnova Flerie Invest Business Sweden's Catalyst

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about XNK Therapeutics

How much funding has XNK Therapeutics raised?

XNK Therapeutics has raised $156K in total funding. The most recent round was Grant. The last funding was announced in October 2023.

Who are XNK Therapeutics's investors?

XNK Therapeutics's investors include Vinnova, Flerie Invest, Business Sweden's Catalyst.

Where is XNK Therapeutics headquartered?

XNK Therapeutics is headquartered in Huddinge, Sweden.

What does XNK Therapeutics do?

XNK Therapeutics is a clinical stage, immunotherapy company.

What stage is XNK Therapeutics at?

XNK Therapeutics is at the Grant stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated October 10, 2023.

MLA

"XNK Therapeutics — Funding & Investors." VCBacked, October 10, 2023, https://www.vcbacked.co/company/xnk-therapeutics. Accessed July 3, 2026.

APA

VCBacked. (2023). XNK Therapeutics — Funding & Investors. Retrieved July 3, 2026, from https://www.vcbacked.co/company/xnk-therapeutics

Wikipedia (cite web)

{{cite web |title=XNK Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/xnk-therapeutics |website=VCBacked |access-date=July 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated October 10, 2023.

Similar Companies in Pharmaceutical

View all

Cannabinoid API Solutions

Blue Sky Specialty Pharmacy

Mount Pleasant$10.0M